Oncology and Hematology
Oncology and Hematology Clinical Practice
Stay current with Oncology and Hematology education that fits how you practice. ReachMD offers practical, on-demand clinical content for oncologists, hematologists, oncology nurses, pharmacists, fellows, APPs, and the full cancer care team. Explore expert discussions, case-based programs, CME/CE opportunities, industry features, and news across solid tumors, hematologic malignancies, biomarker-driven care, immunotherapy, targeted therapy, supportive care, and more.
Use this page to find relevant oncology and hematology content fast. Browse Project Oncology episodes, jump into CME/CE activities, review expert perspectives, or explore timely updates on evolving treatment strategies and standards of care. New content is added regularly, so you can stay current with emerging evidence, guideline updates, and multidisciplinary approaches to cancer care on your schedule.
Start with the latest programs below or browse by content type to find the Oncology and Hematology education most relevant to your practice.
226-240 of 362

The Impact of First-Line Treatment on Subsequent Treatment Options for Metastatic ESCC
MinuteCE®The Impact of First-Line Treatment on Subsequent Treatment Options for Metastatic ESCC

Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
MinuteCE®Effective Monitoring and Management of Adverse Effects in Metastatic ESCC

Second-Line Solutions in Metastatic TNBC: ADC Selection, Sequencing, and Safety
CME/CESecond-Line Solutions in Metastatic TNBC: ADC Selection, Sequencing, and Safety

Timing of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
MinuteCE®Timing of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer

Differential Diagnosis of Indolent Systemic Mastocytosis
MinuteCE®Differential Diagnosis of Indolent Systemic Mastocytosis

Recent Updates on Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
MinuteCE®Recent Updates on Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
- advertisement

Duration of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer
MinuteCE®Duration of Ovarian Function Suppression in Premenopausal HR+ Early-Stage Breast Cancer

Future Directions of Ovarian Function Suppression: Answering Unmet Needs in Premenopausal HR+ Early-Stage Breast Cancer
MinuteCE®Future Directions of Ovarian Function Suppression: Answering Unmet Needs in Premenopausal HR+ Early-Stage Breast Cancer

Diagnosis and Treatment of Systemic Mastocytosis With an Associated Hematologic Neoplasm
MinuteCE®Diagnosis and Treatment of Systemic Mastocytosis With an Associated Hematologic Neoplasm

Accurate Diagnosis and Management of Hereditary Alpha Tryptasemia
MinuteCE®Accurate Diagnosis and Management of Hereditary Alpha Tryptasemia
- advertisement

Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
CME/CEAdvancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow

Virtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care
CME/CEVirtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care








































